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Abstract Adequate means for genotype assignment to pheno- 
type is essential in evolutionary molecular engineering. In this 
study, construction of 'in vitro virus' was carried out in which a 
genotype molecule (mRNA) covalently binds to the phenotype 
molecule (protein) through puromycin on the ribosome in a cell- 
free translation system. Bonding efficiency was ~ 10%, thus 
indicating a population of the in vitro virus to have ~ 1012 
protein variants, this number being 104 that in the phage display. 
The in vitro virus is useful for examining protein evolution in a 
test tube and the results may possibly serve as basis for a general 
method for selecting proteins possessing the most desirable 
functions. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Genotype assignment to the phenotype is essential to Dar- 
winian evolution. For this purpose in nature, the following 
modes of assignment are available: (i) ribozyme-type in which 
an identical molecule carries the genotype and phenotype, (ii) 
virus-type in which a genotype molecule is bound to pheno- 
type molecules, as in the case of bacteriophage fd or M13; 
and (iii) cell-type in which genotype and phenotype molecules 
are present in identical compartments enclosed by a cell mem- 
brane. 
'Evolutionary molecular engineering' using self-replicative 
RNAs was proposed in 1984 [1] and so far ribozyme-type 
assignment has proven appropriate for evolutionary molecular 
engineering owing to its simplicity [2]. But greater progress 
should be possible in this field if the genotype and phenotype 
are different molecules [1]. 
Bonding of a genotype molecule to the phenotype molecule 
is necessary for evolution to proceed smoothly. At present, the 
following has been proposed for evolutionary molecular en- 
gineering: phage display [3], polysome display [4], ribosome 
display [5], encoded combinatorial library [6], and cellstat [7]. 
But these do not permit global search in the sequence space of 
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high dimension such as whole protein sequence space. For 
example, a virus such as bacteriophage can reproduce only 
in the host cells. This problem can be partially solved through 
use of a cell-free translation system. 
In the present study, an 'in vitro virus' was constructed in 
which a genotype molecule (mRNA) binds to the phenotype 
molecule (protein) through puromycin in a cell-free transla- 
tion system and will be amplified through RT-PCR. The life 
cycle of in vitro virus is a test tube version of that of retro- 
virus. The protein can be regarded as a coat protein of the 
virus. In vitro virus is a parasite to a cell-free test tube. It 
would evolve rapidly in it. Puromycin is a very powerful in- 
hibitor of the growth of all cells, through its hindrance of 
chain elongation [8]. Its structure resembles the 3' end of an 
aminoacyl-tRNA molecule, and thus is readily capable of en- 
tering the ribosomal A site to be transferred to nascent poly- 
peptide chains by peptidyl transferase. Covalent bonding of 
mRNA bearing puromycin at the 3'-terminal end to the C- 
terminal end of the encoded protein in a cell-free translation 
system using rabbit reticulocyte lysates is presented in the 
following. 
2. Materials and methods 
2.1. Chemicals and enzymes 
The chemicals and enzymes were reagent grade and purchased from 
the following sources: puromycin from Sigma; rC-13 amidite from 
PerSeptive Biosystems; Tetrazole from Nihon Milipore; tetrabutyl 
ammonium fluoride from Aldrich: T4 DNA ligase and T4 polynucleo- 
tide kinase from New England Biolabs; T4 RNA ligase and protein- 
ase K from Takara; DNA polymerase (AmpliTaq Gold) from Roche; 
mTG(5')ppp(5')G from BRL; T7 RNA polymerase, rabbit reticulo- 
cyte lysate translation system and mung bean nuclease from Promega; 
radiolabelled chemicals from Amersham. Other chemicals were of 
reagent grade. 
2.2. Synthesis qf rCpPur 
rCpPur was produced by phosphoramidite chemistry [9] in the 
liquid phase. Puromycin (50 mg, 92 ~mol) was made anhydrous by 
repeated coevaporation with dry pyridine (3×2 ml). This was fol- 
lowed by the addition of 15 ml of a solution of 4°/,, tetrazole in 
acetonitrile and rC-[3 amidite (177.5 rag, 184 ~tmol). The reaction 
was monitored by silica gel TLC (solvent; chloroform:methanol= 
9:1). After 1 day at room temperature, puromycin ceased to be ap- 
parent on TLC. The solvent was removed in vacuo. A 0.1 M solution 
(3 ml) of I2 in tetrahydrofuran:pyridine:water (80:40:2) was added to 
oxidize the phosphite-triester and stirred at room temperature. After 
1.5 h, the solvent was removed in vacuo and the residue extracted 
with chloroform. The extract was dried over MgSO4 and the solvent 
removed in vacuo. The residue was chromatographed on a column of 
silica gel and eluted with chloroform containing 10% methanol to give 
the protected ribocytidyl-puromycin dimer (Rf 0.32 on silica gel 
TLC). For deprotection of all protecting roups, the protected imer 
was first treated with 80% aqueous acetic acid (0.5 ml) for 1 h and the 
acetic acid was evaporated, was then added to 0.5 ml of a mixture of 
concentrated ammonia:ethanol (2:1). After 15 h ammonia and the 
All rights reserved. 
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solvent were removed in vacuo and the residue was treated with 0.5 
ml of 1 M tetrabutylammonium fluoride in tetrahydrofuran to remove 
the 13-cyanoethyl group. After 30 min, the solvent was removed in 
vacuo and the residue chromatographed on QAE-Sephadex by a lin- 
ear gradient of 0~.5 M triethylamine carbonate. The eluent was col- 
lected and lyophilized twice. The dimer (10 mg) was obtained and 
analyzed by HPLC. Incubation of the dimer with nuclease P1 gave 
a digestion mixture of cytidine and puromycin 5'-phosphate in the 
correct ratios, which was analyzed by HPLC and then also by MAL- 
DI/TOF/MS (PerSeptive Biosystems Voyager). An [M+H] + molecular 
ion at m/z 777 for rCpPur was identified. 
2.3. Construction of the genome of an in vitro virus 
This genome is comprised of mRNA encoding a protein, DNA 
spacer, P-acceptor and rCpPur. The plasmid (pAR3040) containing 
the N-terminal half sequence of human tau protein [101 was used to 
construct the mRNA region, cDNA corresponding to amino acids 1- 
165 of a human tau protein was amplified by PCR using oligonucleo- 
tides primer 1 (5'ATGGCTGAGCCCCGCATGGAGTTCY) and 
primer 2-1 (5'CTCTGCCACTTACTAGGGCTCCCG3') with the 
stop codon or primer 2-2 (5'CTCTGCCACCTTCTTGGGCTCCC3') 
without his stop codon. DNA sequences containing a T7 RNA poly- 
merase promoter, Kozak sequence and sequence corresponding to 
positions 1-25 of a human tau protein were chemically synthesized. 
The purified DNA sequences were fused by PCR in two steps: DNAs 
first amplified in the absence of primers followed by amplification i  
the presence of primer 3 and primer 2 and purified fused DNA tran- 
scribed to mRNA by T7 RNA polymerase in vitro. 
The P-acceptor (5'CTTACTGTCTTTTTTTTTTTTrGrArGrC3'), 
a 25 mer DNA-RNA chimera nucleotide having 4 mer RNA at the 
3'-terminal end was ligated into a 105 mer DNA spacer (5'AAGC- 
GACTCGCGTGGTCTCGCA (T × 66) AATGACCTCCCC3') by T4 
DNA ligase in the presence of splint DNA at 16°C for 2 h. rCpPur 
was phosphorylated byT4 polynucleotide kinase and then ligated into 
the DNA spacer-P-acceptor by T4 RNA ligase at 37°C for 30 min. 
The DNA spacer-P-acceptor-rCpPur wasphosphorylated by T4 poly- 
nucleotide kinase and ligated into the mRNA by T4 RNA ligase at 
4°C for 48 h. Following extraction with phenol, the ligated product 
(in vitro virus genome) was precipitated with ethanol and then with 
polyacrylamide gel (4%)-purified at 60°C. 
2.4. In vitro translation of the mRNA region of the in vitro virus 
genome 
The mRNA region of the in vitro virus genome (0.3-1.2 lag) was 
translated for 20 min at 30°C in 50 pl containing 35 lal rabbit retic- 
ulocyte lysates [11]. Following translation, 1 mg/ml of vanadyl ribo- 
nucleoside complexes wa added to the system followed by cooling on 
ice. The translation products were analyzed on 11.25% acrylamide- 
0.8% bisacrylamide-0.1% SDS gels which were exposed to an imaging 
plate for 30 min for analysis by an imaging analyzer (Fuji Film 
BAS2000). 
3. Results and discussion 
3.1. Construction of  the genome of  the in vitro virus 
Fig. 1 shows the scheme for this construction that was 
conducted using mRNA encoding the N-terminal fragment 
(1-165) of human tau protein with or without a termination 
codon (ochre), DNA spacer, P-acceptor and rCpPur. Trans- 
lation of the constructed genome gave polypeptides in a cell- 
free translation system. Puromycin of the 3'-terminal end of 
the genome entered the A site of the ribosome to covalently 
bind to the C-terminal end of polypeptide. It was then re -  
leased from the ribosome and the in vitro virus particle (vir- 
ion) in which the genotype was connected to the phenotype 
was obtained. This virion was found to be useful for selecting 
proteins possessing the most desirable functions. 
The chain length between a termination codon and puro- 
mycin, presence of a termination codon and 3'-terminal struc- 
ture of a genomic region were all taken into consideration for 
construction of the virus. These were also considered in the 
] ,  "In vitro virus" genome 
mRNA 
2. Cell-free translation 
Polypeptides 
Ribosome 





4. Ribosome release 
1 
"In vitro virus" virion 
l 
Fig. 1. Scheme for the construction of the in vitro virus virion. 
subsequent construction of the following three different ge- 
nomes of the in vitro virus: one with a termination codon 
and without a DNA spacer; one without a termination codon 
and DNA spacer; and finally, one without a termination co- 
don and with DNA spacer. The intermolecular bonding of 
32p-labelled rCpPur to the C-terminal end of N-terminal frag- 
ment (1-165) of human tau protein was examined and the 
results are shown in Fig. 2. Regardless of the presence or 
absence of a termination codon on the genome without a 
DNA spacer, proteins with rCpPur attached to the C-terminal 
residue were synthesized to the same extent. The protein 
bonded to 32p-labelled rCpPur coincided with a monomer of 
the protein incorporated 35S-labelled methionine (the first 
right lane in Fig. 2). When a termination codon was absent 
and a DNA spacer present, the protein bonded to 32p-labelled 
rCpPur was synthesized in considerable amount and three 
time as much was synthesized when the DNA spacer was 
not connected to the 3'-terminal end of mRNA.  Ribosome 
pausing would thus appear to occur in DNA sequences, ac- 
companied by rCpPur binding to the C-terminal end of the 
protein. These results indicate that a protein having rCpPur at 
the C-terminus is efficiently synthesized when a genome with- 
out a stop codon with DNA spacer was used as an mRNA in 
a cell-free translation system. 
Termination is a relatively slow step involving a transla- 
tional pause in rabbit reticulocyte lysates [12]. The rate of 
termination is one-tenth that of elongation [13]. Proteins 
translated from mRNAs without termination codon undergo 
modification by C-terminal addition f tag peptides each con- 
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Fig. 2. lntermolecular bonding of :{2P-labelled rCpPur to the C-ter- 
minal end of N-terminal fragment (1-165) of human tau protein. 
Three in vitro virus genomes: one with a termination codon and 
without a DNA spacer, one without a termination codon and DNA 
spacer and one without a termination codon a d with a DNA 
spacer, were translated in 50 gl containing 35 gl rabbit reticulocyte 
lysates at 30°C for 20 rain. To the mixture 1.15 p.g of the genome 
were added. The final concentration of :~2P-labelled rCpPur was 28 
pM. Translation products were applied onto 11.25% SDS-PAGE. 
Ref (the first right lane), mRNA encoded the N-terminal fragment 
(1 165) of human tau protein was translated in the presence of [asS] 
methionine under the same condition described above. 
taining I1 amino acids [14]. 10Sa RNA capable of folding into 
a tRNA-l ike structure functions as mRNA and tRNA for tag- 
peptides. In this case 10Sa aminoacylated with alanine may be 
incorporated into the A site on ribosomes during ribosome 
pausing [15]. Thus, if ribosome pausing is relatively long, an 
tRNA-l ike molecule such as puromycin or 10Sa may possibly 
be incorporated into an apparently empty A site on the ribo- 
some. 
3.2. Construction q/" an in vitro virus virion in a cell-free 
translation system 
This construction was carried out in a cell-free translation 
system. Examination was initially made of the effects of only 
mRNA encoding the N-terminal fragment (1-165) of tau pro- 
tein on the incorporation of methionine in a cell-free trans- 
lation system using rabbit reticulocyte lysates. As shown in 
Fig. 3A, :~:'S-labelled methionine was incorporated into two 
proteins with molecular weights of ,-,28 kDa and ,-, 55 kDa 
(the first left lane). The former corresponded to the apparent 
molecular weight of a monomer of the N-terminal fragment 
(1-165) of tau protein and the latter to that of its dimer. This 
indicates that mRNA functions as a messenger for the syn- 
thesis of N-terminal fragment (1 -165) of tau protein in vitro. 
Study was then made of the effects of the genome, in which 
mRNA,  DNA spacer (105 met), P-acceptor and rCpPur are 
connected on the incorporation of methionine in the same 
translation system. Except for positions corresponding to 
the monomer and dimer, :~S-labelled methionine was incor- 
porated into a new broad band appearing at a position 
slightly higher than the in vitro virus genome (the first right 
lane). This broad band increased with incubation time (Fig. 
3A) and amotmt of the genome (Fig. 3B). The genome of this 
type thus appears quite likely to bind covalently to the en- 
coded protein through puromycin. For the genome with a 
DNA spacer, many protein bands appeared at regular inter- 
vals at the position of a monomer (Fig. 3A). Ribosome pause 
may thus possibly occur in the DNA spacer moiety of the 
407 
genome followed by the pausing of many ribosomes to pro- 
duce proteins with shorter chain lengths. Bands appeared at 
regular intervals near the monomer after 10 min incubation 
are not due to the cleaved mRNAs by contaminant RNases 
because the mRNA labeled with [:~2p] at the 3'-terminus was 
not cleaved to give discrete bands appeared at regular inter- 
vals (lane 3 in Fig. 4). 
The spacers in the genomes of in vitro virus had chains 
differing in length and the effects of this difference on bonding 
to encoded proteins were examined. Genomes with chain 
lengths of more than 100 mer bound to the encoded proteins 
but genomes with chain length less than 80 mer failed to do so 
(data not shown). 
The covalent bonding of a genotype molecule (mRNA) to 
phenotype molecule (protein) was also studied using :~P-la- 
belled rCpPur in a cell-free translation system (Fig. 4). A 
genome was constructed, consisting of mRNA encoding the 
N-terminal fragment (1 165) of tau protein, DNA spacer (105 
mer), P-acceptor and :*2p-labelled rCpPur. Covalent bonding 
of the genome having :~2P-labelled rCpPur at the 3'-terminal 
end to the C-terminal of the encoded protein was confirmed 
by treatment with mung bean nuclease after translation. Three 
bands were detected after this treatment (lane 4) and the two 
bands were assigned to the monomer and dimer of N-terminal 
fragment (1 165) of tau protein having :~P-labelled rCpPur at 
the C-terminal end. The monomer and dimer detected after 
digestion with mung bean nuclase were completely digested 
with proteinase K and the top band in lane 4 was completely 
digested with RNase TI (data not shown). This result indi- 
(A) 
Ref. 
Incubation time (min) 
5 10 20 40 Ref. 
"In vitro virus" 
~i  ~,-"" v,.o viro~" 
genome 
Dimer-~ ~ ~ 
.ooomer -,- 
(B) 
1 2 3 4 
Fig. 3. Construction of in vitro virus virion in a cell-free translation 
system. A: Time course of intermotecular bonding of the in vitro vi- 
rus genome consisting of mRNA, DNA spacer, P-acceptor and 
rCpPur to its encoded protein. The genome (0.48 pg) was translated 
in 50 gl containing 45 pCi [a~S] methionine and 35 ~al of rabbit re- 
ticulocyte lysates at 30°C. Translation products were applied onto 
11.25% SDS-PAGE. B: Effects of genome concentration on the in- 
termolecular bonding of the genome to the encoded protein. Lane 
1, genome with aZP-labelled rCpPur at the 3'-end; lane 2, genome 
(1.2 lag) without rCpPur at the Y-end; lane 3, genome (0.32 lag) 
with rCpPur at the 3'-end; lane 4, genome (0.64 gg) with rCpPur at 
the Y-end. The genomes in lanes 24  were translated in 50 gl con- 
taining 45 gCi [3~S] methionine and 35 pl rabbit reticulocyte lysates 
at 30°C for 20 min but genome in lane 1 was not translated. The 
samples in lanes 1~, were applied onto 11.25% SDS-PAGE contain- 
ing 8 M urea. 
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Fig. 4. Intermolecular bonding of the in vitro virus genome with 
32p-labelled rCpPur to the C-terminal end of the encoded protein. 
Lane 1, genome was translated at 30°C for 20 min in the presence 
of 45 laCi of [35S] methionine; lane 2, genome with 32p-labelled 
rCpPur at the 3'-end was not translated; lane 3, genome (1 ~tg) 
with 32p-labelled rCpPur at the 3'-end was translated at 30°C for 20 
rain; lane 4, genome (1 ~tg) with 32p-labelled rCpPur at the 3'-end 
was translated at 30°C for 20 rain and then digested with mung 
bean nuclease (90 units) at 37°C for 10 min. Translation products 
were applied onto 11.25% SDS-PAGE. 
cates that the monomer and dimer consist of a protein having 
rCpPur at the C-terminal end. The monomer band may pos- 
sibly have been a contaminant in which the preformed mono- 
mer intermolecularly bonded to 32p-labelled rCpPur remain- 
ing undergoing degradation from the genome in the mixture. 
But this was shown not to be the case since the monomer 
band did not appear before treatment with mung bean nucle- 
ase (lane 3). The formation of the dimer was stimulated by 
connection of a DNA spacer to mRNA (Fig. 3A). The in vitro 
virus genome consisting of mRNA, DNA spacer, P-acceptor 
and rCpPur may thus be concluded to covalently bind to the 
C-terminal end of the encoded protein through puromycin on 
the ribosome in a cell-free translation system. 
The efficiency of intermolecular bonding of the genome to 
the encoded protein was ,~ 10%. A solution of in vitro virus 
genome could be prepared at 40 to 100 pmol/ml, thus showing 
a population of the in vitro virus to contain 2.4,- ,6x 1012 
protein variants, this being 104 times the number in phage 
display [16]. Genotype assignment to the phenotype using 
the in vitro virus makes possible the synthesis of a great 
many mutants, production of different functional proteins, 
elimination of any permeability problem and the incorpora- 
tion of different nonnatural amino acids. Meanwhile, in the 
study of the origin of life, a hypercycle with virus-like mem- 
bers was recently shown to make possible the emergence of 
the first encoded protein as a replicase cofactor and gradual 
evolution of translation activity out of the RNA world [17]. 
Thus the in vitro virus is useful for examining the initial 
protein evolution in the RNP world and for protein engineer- 
ing in a test tube, and is an in vitro alternative to phage 
display. 
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